Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Mini-gastrin analogue, in particular for use in CCK2 receptor positive tumour diagnosis and/or treatment

Mini-gastrin analogue, in particular for use in CCK2 receptor positive tumour diagnosis and/or treatment

US Patent 11623014 · Granted Apr 11, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Transglutaminase conjugation method and linker2024
Transglutaminase conjugation method and linker2024
Isomerically pure 18F-labelled tetrahydrofolates2024
Fibronectin-binding peptides for use in tumor or fibrosis diagnosis and therapy2023
Fibronectin-binding peptides for use in tumor or fibrosis diagnosis and therapy2023
PSMA-binding agents and uses thereof2023
Site-specific conjugation to antibody lysine residues with solid-phase immobiliz2022
Site-specific conjugation to antibody lysine residues with solid-phase immobiliz2022
18F-saccharide-folates2021
18F-labelled folates as PET radiotracers2021
Mini-gastrin analogue, in particular for use in CCK2 receptor positive tumour di2021
Mini-gastrin analogue, in particular for use in CCK2 receptor positive tumour di2021